Thomas W. Rösler

1.3k total citations
33 papers, 932 citations indexed

About

Thomas W. Rösler is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas W. Rösler has authored 33 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Neurology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas W. Rösler's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Alzheimer's disease research and treatments (6 papers) and RNA regulation and disease (4 papers). Thomas W. Rösler is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Alzheimer's disease research and treatments (6 papers) and RNA regulation and disease (4 papers). Thomas W. Rösler collaborates with scholars based in Germany, Egypt and United Kingdom. Thomas W. Rösler's co-authors include Günter U. Höglinger, Matthias Höllerhage, Thomas Koeglsperger, Niko-Petteri Nykänen, Hong Xu, Wolfgang Wurst, Wolfgang H. Oertel, Ulrich Müller, Anderson de Andrade and Thomas Carlsson and has published in prestigious journals such as PLoS ONE, Neurology and Analytical Biochemistry.

In The Last Decade

Thomas W. Rösler

32 papers receiving 923 citations

Peers

Countries citing papers authored by Thomas W. Rösler

Since Specialization

Citations

This map shows the geographic impact of Thomas W. Rösler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Rösler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Rösler more than expected).

Fields of papers citing papers by Thomas W. Rösler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Rösler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Rösler. The network helps show where Thomas W. Rösler may publish in the future.

Co-authorship network of co-authors of Thomas W. Rösler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Rösler. A scholar is included among the top collaborators of Thomas W. Rösler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Rösler. Thomas W. Rösler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Constitutive expression of the deubiquitinating enzyme CYLD does not affect microglia phenotype or function in homeostasis and neuroinflammation 2024 ·Journal of Molecular Medicine ·Eva Schramm, (unknown), (unknown), (unknown), Thomas W. Rösler, (unknown), (unknown), Khalad Karram, Esther von Stebut, Michael J. Schmeißer, Ari Waisman	1
2	Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue 2023 ·Acta Neuropathologica Communications ·(unknown), Sigrid C. Schwarz, Thomas W. Rösler, Thomas Arzberger, Steve Gentleman, Otto Windl, Mandy Krumbiegel, André Reis, Viktoria Ruf, Jochen Herms, Günter U. Höglinger	9
3	CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants 2023 ·Viruses ·Thomas Bukur, Pablo Riesgo-Ferreiro, Patrick Sorn, Ranganath Gudimella, Johannes Hausmann, Thomas W. Rösler, Martin Löwer, Barbara Schrörs, Uğur Şahin	2
4	Evidence for pathogenicity of variant ATM Val1729Leu in a family with ataxia telangiectasia 2021 ·Neurogenetics ·Ali Shalash, Thomas W. Rösler, Mohamed Salama, Manuela Pendziwiat, Stefanie H. Müller, Franziska Hopfner, Günter U. Höglinger, Gregor Kuhlenbäumer	3
5	Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates 2021 ·PLoS ONE ·Barbara Schrörs, Pablo Riesgo-Ferreiro, Patrick Sorn, Ranganath Gudimella, Thomas Bukur, Thomas W. Rösler, Martin Löwer, Uğur Şahin	26
6	Alpha-synuclein fragments trigger distinct aggregation pathways 2020 ·Cell Death and Disease ·(unknown), (unknown), Niko-Petteri Nykänen, Matthias Höllerhage, Andreas Schmidt, Frits Kamp, Viktoria Ruf, Wolfgang Wurst, Thomas W. Rösler, Günter U. Höglinger	27
7	Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons 2019 ·Neuropharmacology ·Matthias Höllerhage, (unknown), Thomas W. Rösler, Wolfgang Wurst, Christian Behrends, Günter U. Höglinger	15
8	Disease-modifying strategies in primary tauopathies 2019 ·Neuropharmacology ·Thomas W. Rösler, Márcia Costa, Günter U. Höglinger	7
9	Four-repeat tauopathies 2019 ·Progress in Neurobiology ·Thomas W. Rösler, Amir Tayaranian Marvian, Matthias Brendel, Niko-Petteri Nykänen, Matthias Höllerhage, Sigrid C. Schwarz, Franziska Hopfner, Thomas Koeglsperger, Gesine Respondek, (unknown), Johannes Levin, Victor L. Villemagne, Henryk Barthel, Osama Sabri, Ulrich Müller, Wassilios G. Meissner, Gábor G. Kovács, Günter U. Höglinger	137
10	Tauopathien 2018 ·Der Nervenarzt ·Gábor G. Kovács, Gesine Respondek, Thilo van Eimeren, (unknown), Johannes Levin, Ulrich Müller, Sigrid C. Schwarz, Thomas W. Rösler, (unknown), Günter U. Höglinger	6
11	K-variant BCHE and pesticide exposure: Gene-environment interactions in a case–control study of Parkinson’s disease in Egypt 2018 ·Scientific Reports ·Thomas W. Rösler, Mohamed Salama, Ali Shalash, Eman M. Khedr, (unknown), Gharib Fawi, (unknown), (unknown), (unknown), Mohamed El‐Gamal, (unknown), (unknown), (unknown), (unknown), Ulrich Müller, Astrid Dempfle, Gregor Kuhlenbäumer, Günter U. Höglinger	17
12	PERK activation mitigates tau pathology in vitro and in vivo 2017 ·EMBO Molecular Medicine ·(unknown), Hong Xu, Thomas W. Rösler, Anderson de Andrade, Peer‐Hendrik Kuhn, Stefan F. Lichtenthaler, Thomas Arzberger, Konstanze F. Winklhofer, Ulrich Müller, Günter U. Höglinger	90
13	Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild‐type and MAPT transgenic mice 2016 ·Journal of Neurochemistry ·(unknown), (unknown), (unknown), Hong Xu, Gesine Respondek, Matthias Höllerhage, Thomas W. Rösler, Emilie Bony, Jessica Le Ven, Vincent Guérineau, Isabelle Schmitz‐Afonso, Pierre Champy, Wolfgang H. Oertel, Elizabeth Sumi Yamada, Günter U. Höglinger	24
14	Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice 2014 ·PLoS ONE ·Matthias Höllerhage, (unknown), Anderson de Andrade, Gesine Respondek, Hong Xu, Thomas W. Rösler, Mohamed Salama, Thomas Carlsson, Elizabeth Sumi Yamada, (unknown), Michel Goedert, Wolfgang H. Oertel, Günter U. Höglinger	16
15	Diesterified Derivatives of 5-Iodo-2′-Deoxyuridine as Cerebral Tumor Tracers 2014 ·PLoS ONE ·Thomas W. Rösler, Andreas Matusch, Damiano Librizzi, Óscar Arias-Carrión, Nils Freundlieb, Helmut Hoeffken, Wolfgang H. Oertel, Candan Depboylu, Günter U. Höglinger	2
16	Systemic administration of neuregulin‐1β₁ protects dopaminergic neurons in a mouse model of Parkinson’s disease 2011 ·Journal of Neurochemistry ·Thomas Carlsson, (unknown), Matthias Höllerhage, Candan Depboylu, Óscar Arias-Carrión, (unknown), Thomas W. Rösler, Wojciech Woźny, Gerhard Schwall, Karlfried Groebe, Wolfgang H. Oertel, Patrik Brundin, André Schrattenholz, Günter U. Höglinger	63
17	Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation 2011 ·Chemical Biology & Drug Design ·(unknown), Thomas W. Rösler, (unknown), Rudolf Matusch, Aria Baniahmad	18
18	Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1 2011 ·Neuropharmacology ·Thomas W. Rösler, Candan Depboylu, Óscar Arias-Carrión, Wojciech Woźny, Thomas Carlsson, Matthias Höllerhage, Wolfgang H. Oertel, André Schrattenholz, Günter U. Höglinger	26
19	Packing density of slurry‐packed capillaries at low aspect ratios 2008 ·Journal of Separation Science ·(unknown), Thomas W. Rösler, Ulrich Tallarek	34
20	Characterization of yeast cultivations by steric sedimentation field-flow fractionation 1992 ·Analytical Biochemistry ·Sabrina Hoffstetter‐Kuhn, Thomas W. Rösler, Markus Ehrat, H.M. Widmer	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact